Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the weight loss ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

Other pharmaceutical companies are also entering the race to develop oral GLP-1 treatments. Eli Lilly is testing an experimental drug called orforglipron which targets the same pathway as semaglutide.

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences. Review: ...

Glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) are entero-pancreatic hormone-based treatments first approved in 2005 for type 2 diabetes (T2D). They are now commonly prescribed for weight ...